FR2509725B1 - - Google Patents

Info

Publication number
FR2509725B1
FR2509725B1 FR8113791A FR8113791A FR2509725B1 FR 2509725 B1 FR2509725 B1 FR 2509725B1 FR 8113791 A FR8113791 A FR 8113791A FR 8113791 A FR8113791 A FR 8113791A FR 2509725 B1 FR2509725 B1 FR 2509725B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8113791A
Other languages
French (fr)
Other versions
FR2509725A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Choay SA
Original Assignee
Choay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay SA filed Critical Choay SA
Priority to FR8113791A priority Critical patent/FR2509725A1/en
Publication of FR2509725A1 publication Critical patent/FR2509725A1/en
Application granted granted Critical
Publication of FR2509725B1 publication Critical patent/FR2509725B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR8113791A 1981-07-15 1981-07-15 3-Phenyl:thio-1-propanol normolipaemic cpds. - e.g. 3-4-chloro-phenyl-thio 1-methyl 1-ethyl or propyl-propanol, used to treat atherosclerosis etc. Granted FR2509725A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8113791A FR2509725A1 (en) 1981-07-15 1981-07-15 3-Phenyl:thio-1-propanol normolipaemic cpds. - e.g. 3-4-chloro-phenyl-thio 1-methyl 1-ethyl or propyl-propanol, used to treat atherosclerosis etc.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8113791A FR2509725A1 (en) 1981-07-15 1981-07-15 3-Phenyl:thio-1-propanol normolipaemic cpds. - e.g. 3-4-chloro-phenyl-thio 1-methyl 1-ethyl or propyl-propanol, used to treat atherosclerosis etc.

Publications (2)

Publication Number Publication Date
FR2509725A1 FR2509725A1 (en) 1983-01-21
FR2509725B1 true FR2509725B1 (en) 1984-09-07

Family

ID=9260514

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8113791A Granted FR2509725A1 (en) 1981-07-15 1981-07-15 3-Phenyl:thio-1-propanol normolipaemic cpds. - e.g. 3-4-chloro-phenyl-thio 1-methyl 1-ethyl or propyl-propanol, used to treat atherosclerosis etc.

Country Status (1)

Country Link
FR (1) FR2509725A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69691A (en) * 1982-09-23 1988-01-31 Merck Frosst Canada Inc Leukotriene antagonists,their preparation and pharmaceutical compositions containing them
DE3366107D1 (en) * 1982-09-30 1986-10-16 Merck Frosst Canada Inc Leukotriene antagonists, their production, and compositions containing them
CA1242195A (en) * 1983-07-18 1988-09-20 David K. Herron Leukotriene antagonists
US4764521A (en) * 1983-07-18 1988-08-16 Eli Lilly And Company Leukotriene antagonists and a method of use there as
CA1316932C (en) * 1985-05-20 1993-04-27 Richard A. Mueller Methods and compositions for inhibiting lipoxygenase
US5229421A (en) * 1985-05-20 1993-07-20 G. D. Searle & Co. Methods and compositions for inhibiting lipoxygenase
ES2060124T3 (en) * 1989-06-06 1994-11-16 Ciba Geigy Ag NEW SULFONILUREAS.
JP4329905B2 (en) 2001-12-27 2009-09-09 第一三共株式会社 β-amyloid protein production / secretion inhibitor
KR20060066057A (en) 2003-06-30 2006-06-15 다이이찌 세이야꾸 가부시기가이샤 Heterocyclic methyl sulfone derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2880137A (en) * 1956-03-26 1959-03-31 Kendall & Co Fungicidal preparations
US3879544A (en) * 1973-05-09 1975-04-22 Carter Wallace Method for suppressing histamine release

Also Published As

Publication number Publication date
FR2509725A1 (en) 1983-01-21

Similar Documents

Publication Publication Date Title
FR2499246B1 (en)
FR2499844B3 (en)
FR2503896B1 (en)
DE3249628A1 (en)
FR2489954B1 (en)
FR2500445B1 (en)
FR2499354B1 (en)
FR2499331B1 (en)
FR2500018B1 (en)
FR2500553B1 (en)
CH655537B (en)
FR2498471B3 (en)
DE3249562A1 (en)
FR2497466B3 (en)
FR2501152B1 (en)
FR2499326B1 (en)
FR2502383B1 (en)
FR2499831B1 (en)
FR2509725B1 (en)
FR2500526B1 (en)
FR2500370B3 (en)
FR2497534B1 (en)
DE3106138C2 (en)
FR2499001B3 (en)
DE3690711T1 (en)

Legal Events

Date Code Title Description
ST Notification of lapse